Pharmaceutical trade group PhRMA put out a series of infographics to accompany its reports on the 771 cancer drugs in development, telling their take on the cancer therapeutics landscape. It’s actually pretty illustrative:
Pharmaceutical trade group PhRMA put out a series of infographics to accompany its reports on the 771 cancer drugs in development, telling their take on the cancer therapeutics landscape. It’s actually pretty illustrative:
Pharmaceutical trade group PhRMA put out a series of infographics to accompany its reports on the 771 cancer drugs in development, telling their take on the cancer therapeutics landscape. It’s actually pretty illustrative: